Advertisement
Advertisement
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.64
USDSponsored
-0.09
-3.30%
Sep 11, 15:59 UTC -4
Closed
After-Market
2.71
+0.07
+2.80%
Protalix BioTherapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 218.67M |
| Beta | 0.02 |
| Earnings Per Share (EPS) | 0.23 |
| Price-to-Book (P/B) Ratio | 3.01 |
| Operating Margin | 23.50% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | 11.61 |
| Return on Equity (ROE) | 31.60% |
| Current Ratio | 2.94% |
| Free Cash Flow | 10.27M |
